FDA Updates Its Microbiological Safety Webpage Amid Recall Flurry
This article was originally published in The Rose Sheet
Gilchrist & Soames’ recall of bath and body products due to microbial contamination marks a five-month trend in FDA’s enforcement reports. On its Microbiological Safety webpage, updated Feb. 12, FDA refers to a public meeting it held on the issue in 2011, where industry representatives warned that a shrinking preservative palette could put consumers at risk.
You may also be interested in...
G&S, which manufactures personal-care products for hotels and spas worldwide, recalled more than 2 million potentially contaminated units of bath and body products last year, but its regulatory compliance issues are not behind it yet. In a March 16 warning letter, FDA cites the firm for inspection failings and product sample analyses that render its products adulterated under US cosmetics law.
Recognizing "a general lack of awareness regarding the important role preservatives have in cosmetic products and the potential impact on public health should they be absent," the International Cooperation on Cosmetic Regulation publishes a two-part Frequently Asked Questions document summarizing the issue for consumers and a more technical audience.
Infographic – An analysis by "The Rose Sheet" of FDA data from 2011-2015 finds bacterial or mold contamination to be the most frequently cited rationale for cosmetic recalls reported during the five-year period. Click the buttons in the interactive graphic below to view and compare data.